期刊文献+

Kallmann综合征分子遗传学研究进展 被引量:4

Molecular genetics of Kallmann syndrome: An update
下载PDF
导出
摘要 Kallmann综合征(KS)是一种临床和遗传异质性疾病,呈家族性或散发性发病。Ks是由胚胎时期嗅球、嗅束的异常发育致使GnRH-1神经细胞不能完成从鼻基板迁移至下丘脑这一过程所引起。GnRH分泌不足导致低促性腺激素性腺功能减退,嗅球、嗅束的异常发育或缺如引起嗅觉丧失。除上述典型症状外,KS患者还可以表现出一些非生殖和非嗅觉表型。KS分子遗传学机制十分复杂,目前只有6个KS致病基因被鉴定。KAL1基因与KS的X连锁隐性遗传模式相关。成纤维细胞生长因子受体1基因(FGFR1/KAL2)和成纤维细胞生长因子8基因(FGFS/KAL6)与常染色体显性遗传模式有关。但是这6个基因的突变只能解释25%~30%的KS病例,提示还有其他KS致病基因有待发现。本文就KS致病基因的研究进展、临床诊断和治疗作一综述。 Kallmann syndrome (KS) is a clinically and genetically heterogeneous disorder that occurs in either an inherited or a sporadic manner. KS results from failed embryonic migration of GnRH-1 neurons from the nasal placode to the hypothalamus, due to the abnormal development of olfactory nerves and bulbs. Hypogonadotropic hypogonadism is related to GnRH deficiency, and anosmia is associated with the absence or hypoplasia of olfactory bulbs 8nd tracts. KS patients can also present some non-reproductive or non-olfactory anomalies in addition to the above typical symptoms. For the high complexity of the molecular genetic mechanism of KS, to date, only 6 KS-related genes have been identified. The KAL1 gene is responsible for the X chromosome-linked recessive form of KS, while the fibroblast growth factor receptor 1 (FGFR1/KAL2) and fibroblast growth factor 8 (FGFS/KAL6) genes are related to the au- tosomal dominant form of the disease. However, the mutations in these 6 genes account for only about 25 - 30% of all KS cases, which suggests that other pathogenic genes involved in KS remain to be discovered. This article presents an overview on the studies of the pathogenic genes, clinical diagnosis and treatment of KS.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2011年第4期361-365,共5页 National Journal of Andrology
基金 吉林省科技厅资助项目(20080444-3)~~
关键词 KALLMANN综合征 GnRH-1 KAL1基因 FGFR1/KAL2基因 PROKR2/KAL3基因 PROK2/KAL4基因 CHDT/KAL5基因 FGFS/KAL6基因 Kallmann syndrome GnRH-1 KAL1 FGFR1/KAL2 PROKR2/KAL3 PROK2/KAb4 CHITI/KAL5 FGF8/ KAL6
  • 相关文献

参考文献30

  • 1Dode C, Hardelin JP. Kallmann Syndrome. Eur J Hum Genet, 2009, 17(2): 139-146.
  • 2Whitlock KE. Origin and development of GnRH neurons. Trends Endocrinol Metab, 2005, 16(4) : 145-151.
  • 3Wray S. From nose to brain: Development of gonadotrophin-releasing hormone-1 neurones. J Neuroendocrinol, 2010, 22 (7) : 743-753.
  • 4邓春华.Kallmann氏综合征[J].男性学杂志,1997,11(4):242-243. 被引量:2
  • 5Ballabio A, Andria G. Deletions and translocations involving the distal short arm of the human X chromosome: Review and hypotheses. Hum Mol Genet, 1992, 1 (4) : 221-227.
  • 6Legouis R, Hardelin JP, Levilliers J, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell, 1991,67 (2) : 423-435.
  • 7Hardelin JP, Levilliers J, del Castillo I, et al. X chromosomelinked Kallmann syndrome : Stop mutations validate the candidate gene. Proc Natl Acad Sci USA, 1992, 89(17) : 8190-8194.
  • 8Cadman SM, Kim SH, Hu Y, et al. Molecular pathogenesis of Kailmann's syndrome. Horm Res, 2007, 67 (5) : 231-242.
  • 9Bhagavath B, Xu N, Ozata M, et al. KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans. Mol Hum Reprod, 2007, 13(3) : 165-170.
  • 10Dode C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet, 2003, 33(4) : 463465.

二级参考文献24

  • 1郝丽君,崔英霞,王云华,商学军,黄宇烽.Kallmann综合征的诊断与鉴别诊断[J].中华男科学杂志,2005,11(10):765-766. 被引量:9
  • 2Todo T, Usui M, Takakura K. Treatment Of severe intraventricular infusion of urokinase [J] . J Nenrosurg, 1991, 74 (3) : 81.
  • 3Duke VM, Winyard PJ, Thorogood P, et al. KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development [J] . Mol Cell Endocrinoi, 1995, 110 (1) : 73.
  • 4Cadman SM, Kim SH, Hu Y,et al. Molecular pathogenesis of Kalimann's syndrome [ J]. Horm Res, 2007,67 ( 5 ) :231.
  • 5Dissaneevate P, Wame GL, Zaeharin MR. Clinical evaluation in isolated hypogonadotrophic hypogonadism ( Kallmann syndrome) [ J] . J Pediatr Endocrinol Metab, 1998, 11 (5): 631.
  • 6Bhagavath B, Robert H, Podolsky M, et al. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism [J] . Fertil Steril, 2006, 85 (3): 7062.
  • 7Fechner A, Fong S, McGovern P. A review of Kallmann syndrome: genetics, pathophysiology, and clinical management [J] . Obstet Gyneeol Surv, 2008, 63 (3): 189.
  • 8Dode C, Teixeira L, Levilliers J, et al. Kallmann syndrome: mutations in the genes encoding prokineticin -2 and prokineticin receptor- 2 [J] . PLOS Genet, 2006, 2:e175.
  • 9MacColl G, Bouloux P, Quinton R. Kallmann syndrome: adhesion, afferents, and anosmia [J]. Neuron, 2002, 34 (5): 675.
  • 10Ballabio A, Andria G. Deletions and transloeations involving the distal short arm of the human X chromosome [J]. Hum Mol Genet, 1992, 1 (4) : 221.

共引文献13

同被引文献22

  • 1郝丽君,崔英霞,王云华,商学军,黄宇烽.Kallmann综合征的诊断与鉴别诊断[J].中华男科学杂志,2005,11(10):765-766. 被引量:9
  • 2郝丽君,崔英霞.Kallmann综合征的研究进展[J].中华男科学杂志,2006,12(7):647-649. 被引量:6
  • 3Kaminski BA, Palmert MR. Genetic control of pubertal timing Curt" Opin Pediatr, 2008, 20(4) : 458-464.
  • 4Hardelin JP, Dod6 C. The complex genetics of Kallmann syndrome KAL1, FGFR1, FGF8, PROKR2 PROK2, et al. Sex Dev 2008, 2(4-5) : 181-193.
  • 5Dod6 C, Hardelin JP. Kallmann syndrome. Eur J Hum Genet 2009, 17( 2): 139-146.
  • 6Fillion M, Deal CL, Van Vliet G. Normal minipuberty of infancy in boys with Prader-Willi syndrome. J Pediatr, 2006, 149 (6) : 874-876.
  • 7Grumbach MM. A window of opportunity : The diagnosis of gona- dotropin deficiency in the male infant. J Clin Endocrinol Metab, 2005, 90(5) : 3122-3127.
  • 8Lieblich JM, Rogol AD, White BJ, et al. Syndrome of anosmia with hypogonadotropic hypogonadism ( Kallmann syndrome ) : Clinical and laboratory studies in 23 cases. Am J Med, 1982, 73 (e4) : 506-519.
  • 9Miyagawa Y, Tsujimura A, Matsumiya K, et al. Outcome of go_ nadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: A 30-year retrospec- tive study. J Urol, 2005, 173(6) : 2072-2075.
  • 10Btichter D, Behre HM, Kliesch S, et al. Pulsatile GnRH or hu- man chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: A review of 42 cases. Eur J Endocrinol, 1998, 139 (3) : 298- 303.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部